Chronic Myeloid Leukemia

CHRONIC MYELOID LEUKEMIA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.

CHRONIC MYELOID LEUKEMIA NEWS

Child patient with her mother.

Factors That Impact HRQOL in Pediatric Patients With Chronic Myeloid Leukemia

November 16, 2021

Pharmacist looking at boxed drugs.

Comparison of Generic and Branded Imatinib for Patients With Chronic Myeloid Leukemia

November 4, 2021

Scemblix Approved for Ph+ Chronic Myeloid Leukemia in Chronic Phase

November 2, 2021

Doctor using stethoscope on a female patient.

Algorithm Assesses Risk of Major Adverse Cardiovascular Events in TKI-Treated CML

November 1, 2021

Pharmacists looking at a shelf full of drugs.

Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs

October 27, 2021

Next post in Chronic Myeloid Leukemia

Pharmacist looking at boxed drugs.

Comparison of Generic and Branded Imatinib for Patients With Chronic Myeloid Leukemia